How Seniors Can Lower Medicare Drug Costs in 2026

Prescription drug costs are still a major expense for older Americans. This guide explains the latest 2026 Medicare Part D caps, government pricing actions, TrumpRx developments, federal programs, and options that may help reduce out-of-pocket prescription costs.

Most of us take medications, often more than one—the number of medications we take increases every year. Recent national surveys and health analyses indicate that most Americans age 65 and older take multiple prescription drugs, with many taking 4 or more medications regularly. In one analysis, more than half of adults 65 + reported taking four or more prescription drugs.

Around 42 percent to 44 percent of older adults (65+) use five or more medications, a pattern that has been increasing over time.

You walk up to the pharmacy counter expecting one price — and hear another. Even with Medicare, prescription costs can strain your budget. For many older adults living on fixed incomes, those costs matter deeply.

You’re not alone.

Understanding how Medicare prescription drug coverage has changed in 2026 — and what assistance may be available — can help protect both your health and your retirement savings.

What Medicare Part D Covers in 2026

2026 Cost Caps and How They Work

• Medicare Part D prescription drug plans have a maximum deductible of $615 in 2026, though some plans may waive this.
• Once you meet your plan’s deductible (if any), you start paying copays or coinsurance.
• Medicare Part D beneficiaries now benefit from an out-of-pocket limit on drug costs, historically around $2,100 in 2026, which protects you once you reach that threshold.

This means that after your total drug spending hits the annual cap, you should pay nothing more for covered prescriptions for the rest of the year under your Part D plan — though specifics vary by plan.

Medicare Price Negotiation in 2026

The Inflation Reduction Act (IRA) allows Medicare to negotiate prices for certain high-cost drugs directly. Savings from this program help reduce costs for beneficiaries.

Negotiated prices for the first 10 Medicare Part D drugs selected under the Inflation Reduction Act took effect on January 1, 2026, marking the first year beneficiaries saw federally negotiated lower prices for high-cost brand medications.

Independent analysis suggests that negotiated prices for these drugs could result in several billion dollars in combined savings for the Medicare program and for beneficiaries in 2026.

In addition, the Centers for Medicare & Medicaid Services (CMS) has announced 15 more Part D drugs selected for negotiation, with negotiated maximum fair prices scheduled to take effect on January 1, 2027. These include widely prescribed medications used to treat conditions such as type 2 diabetes, HIV, arthritis, asthma, and cancer.

These negotiated prices apply to drugs covered under Medicare Part D and aim to lower both what the program and beneficiaries pay as prescription drug costs over time.

These negotiated prices apply to drugs covered under Medicare Part D and aim to lower what the program and beneficiaries pay.

For too long, seniors and taxpayers have paid the price for skyrocketing prescription drug costs. Under President Trump’s leadership, CMS is taking strong action to target the most expensive drugs in Medicare, negotiate fair prices, and make sure the system works for patients — not special interests.” — Dr. Mehmet Oz, Administrator, Centers for Medicare & Medicaid Services.

Manufacturer-Sponsored Patient Assistance Programs

Manufacturer-Sponsored Patient Assistance Programs, often called PAPs, are programs run directly by pharmaceutical companies to help eligible patients obtain brand-name medications at reduced or no cost.

These PAPs are not discount coupons or retail pharmacy savings cards. They are formal assistance programs designed primarily for individuals who meet specific income criteria and who lack adequate prescription coverage or face high out-of-pocket costs.

Each manufacturer sets its own eligibility rules. Most programs require proof of income, documentation of insurance coverage, and a valid prescription from a licensed healthcare provider. Income thresholds vary but may extend well beyond federal poverty levels, meaning some middle-income seniors may still qualify. Approval is not automatic, and benefits are typically granted for a defined period, often requiring annual renewal.

Patient Assistance Programs generally apply to brand-name medications that remain under patent protection and carry higher retail prices. For Medicare beneficiaries, eligibility can be more complex. Some programs restrict assistance if a patient has government coverage, while others provide support when out-of-pocket costs remain high despite Medicare Part D benefits. Because rules differ by drug and manufacturer, careful review of program guidelines is essential.

For older adults managing multiple chronic conditions, these programs can provide meaningful financial relief. However, applications can involve detailed paperwork and coordination between the patient, physician, and manufacturer.

Seniors should compare manufacturer assistance options with other available resources, including federal programs such as Extra Help and state counseling services, to determine which approach best fits their situation.

There are nationwide services that help individuals enroll in these manufacturer-sponsored patient assistance programs — specifically built to handle the complexity that keeps most people from applying in the first place.

These services, like Rx Advocates, involve identifying which programs you may qualify for, completing the application on your behalf, and managing ongoing renewals. For seniors juggling multiple prescriptions, the potential savings from patient assistance programs can be substantial.

Ultimately, Manufacturer-Sponsored Patient Assistance Programs can serve as one tool among several for addressing prescription affordability. Understanding eligibility requirements, documentation needs, and renewal timelines helps ensure that patients make informed decisions and avoid unexpected disruptions in medication access.

What TrumpRx Is — and What It Isn’t

In February 2026, the federal government launched TrumpRx.gov, a new prescription drug website intended to offer lower retail prices on many medications to the general public.

Here’s what you need to know:

• TrumpRx was created in 2026 as a government-operated drug price portal designed to help people find lower prices on retail prescription medications.
• The site promotes price reductions on selected drugs intended to reflect prices paid in other developed countries (a “most-favored-nation” pricing approach).
• TrumpRx may show deep discounts on medications — but experts note that some discounts may not apply to people covered by Medicare or Medicaid because government insurance rules can require patients to pay standard plan costs before any savings apply.

In other words, if you’re a Medicare beneficiary, TrumpRx prices might not reduce your Part D cost directly unless your plan structure allows it, or unless you’re paying cash for a prescription outside your plan.

Additionally:

• There’s ongoing legal and regulatory scrutiny of direct-to-consumer programs like TrumpRx, with federal advisory opinions raising questions about how they fit existing anti-kickback and patient safety rules.

That means TrumpRx should be seen as one possible tool for comparing prices, not a guaranteed replacement for Medicare drug coverage or prescription cost savings.

Federal Programs to Explore First

Before considering retail discount tools like TrumpRx, review these well-established government programs that may help you reduce Medicare prescription costs:

Extra Help (Low-Income Subsidy)

• Offers help with Part D premiums, deductibles, and copays for qualifying individuals.
• Eligibility is based on income and assets, with limits updated annually.
• More information: ssa.gov/medicare/part-d-extra-help

State Health Insurance Assistance Programs (SHIP)

Every state offers free Medicare counseling through SHIP, which can help you:

• Compare Part D plans
• Understand coverage changes
• Determine eligibility for Extra Help

Find local counseling at shiphelp.org

State Pharmaceutical Assistance Programs (SPAPs)

Some states offer additional prescription assistance programs to residents, depending on eligibility.

Your local SHIP counselor can tell you whether this option exists where you live.

Medicare Covers Doctors, Hospitals, and Drugs, Not Long-Term Care

It’s also important to understand how Medicare handles care beyond medications:

• Medicare pays for hospital care, doctor services, and covered drugs, but
• It does not pay for extended long-term custodial care (help with daily activities like bathing or eating) beyond limited skilled nursing care coverage (typically up to about 100 days after a qualifying hospital stay).

When planning for retirement, recognize that unless you have Long-Term Care Insurance or qualify for Medicaid due to limited financial resources, the cost of long-term custodial care will likely be your responsibility.

Practical Steps You Can Take

If you’re concerned about rising drug costs:

1. Review your current Medicare Part D plan and how much you’re actually paying.
2. Contact your state SHIP counselor for free advice.
3. Apply for Extra Help if your income and assets qualify.
4. Ask your doctor whether lower-cost alternatives are medically appropriate.
5. Compare retail pricing tools like TrumpRx with your Part D coverage costs.

It’s also important to remember that Medicare Part B and Part D premiums are income-based. Under the Income-Related Monthly Adjustment Amount (IRMAA) rules, higher-income beneficiaries pay more for both Part B medical coverage and Part D prescription drug coverage.

Medicare uses your modified adjusted gross income from two years prior to determine your premium level. That means if you increase your income in a given year — for example, by selling investments or other assets to help pay for long-term care — your reported income may rise enough to trigger higher premiums in a future year.

When planning how to cover extended care expenses, consider how asset liquidation or large withdrawals could affect not only taxes but also your Medicare premiums.

Note: Long-Term Care Insurance benefits come to you tax-free, so there is no tax event when receiving benefits from a qualified LTC policy.

Final Word

Prescription affordability is a central issue for older adults managing chronic conditions. While 2026 reforms like the annual out-of-pocket cap and Medicare price negotiations help, costs can still compare unfavorably with out-of-pocket needs early in the year or for specific brand drugs.

Explore federal assistance first, understand your Part D costs, and use tools like TrumpRx carefully — but don’t assume they’ll replace the protections your Medicare plan offers.

Taking these steps today can help protect your health and your retirement security.